Kenya To Spend $61M To Increase Antiretroviral Treatment Access, Health Ministry Says
Main Category: HIV / AIDSArticle Date: 08 Apr 2008 - 11:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Kenya's Ministry of Health on Sunday in a statement announced that the country will spend about $61 million next year to increase access to antiretroviral drugs, AFP/Yahoo! News reports. According to the health ministry, about 190,000 people living with HIV/AIDS have access to no-cost antiretrovirals, with an increase of 5,000 new people monthly.
The government -- with support from the Global Fund To Fight AIDS, Tuberculosis and Malaria and other foreign donors -- will spend about $61 million to increase access to the drugs. The health ministry on Sunday said it will ensure there is a buffer stock of antiretrovirals for up to nine months. According to AFP/Yahoo! News, the number of people in need of antiretrovirals is estimated to increase by 60,000 to 250,000 people by next year (AFP/Yahoo! News, 4/6).
According to a 2007 UNAIDS report, HIV prevalence in Kenya has decreased from a high of 14% in the mid-1990s to 5% in 2006 (Kaiser Daily HIV/AIDS Report, 2/27). The disease has "overturned decades of health care gains" made in the country and threatens development efforts if its spread is not reversed, AFP/Yahoo! News reports (AFP/Yahoo! News, 4/6).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/103132.php>
APA
http://www.medicalnewstoday.com/releases/103132.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



